FGFR1 as a novel prognostic and predictive biomarker in squamous cell cancers of the lung and the head and neck area

被引:20
|
作者
von Maessenhausen, Anne [1 ]
Franzen, Alina [1 ]
Heasley, Lynn [2 ]
Perner, Sven [1 ]
机构
[1] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany
[2] Univ Colorado, Dept Craniofacial Biol, Aurora, CO USA
关键词
FGFR1; lung cancer; head and neck cancer; therapeutic target; biomarker;
D O I
10.3978/j.issn.2305-5839.2013.06.08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FGFR1 amplification is a genomic aberration recently identified in various types of cancer. Especially squamous cell carcinomas of the lung and the head and neck show this genetic alteration in high frequencies. In these cancers FGFR1 is not only a therapeutic target but does also serve as a biomarker that correlates with parameters of worse outcome. However, since FGFR1 amplification does not always correlate with high protein expression defining the best predictive biomarker for a FGFR1 targeted therapy is of great importance.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline M. W.
    Noorlag, Rob
    de Bree, Remco
    Lieftink, Cor
    van Es, Robert J. J.
    Bernards, Rene
    Willems, Stefan M.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3884 - 3893
  • [2] FGFR1 as a prognostic biomarker and potential therapeutic target in head and neck squamous cell carcinoma.
    Willems, Stefan M.
    Koole, Koos
    Brunen, Diede
    van Kempen, Pauline Md
    Noorlag, Rob
    Bijlsma, Rhode
    van Es, RobertJ. J.
    Lieftink, Cor
    de Bree, Remco
    Bernards, Rene
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck Squamous Cell Carcinoma (SCC)
    Koole, K.
    Brunen, D.
    van Kempen, P.
    Noorlag, R.
    de Bree, R.
    Lieftink, C.
    van Es, R.
    Bernards, R.
    Willems, S.
    VIRCHOWS ARCHIV, 2016, 469 : S31 - S31
  • [4] FGFR1 amplification in squamous cell lung cancers
    Cote, Michele L.
    Bepler, Gerold
    Land, Susan
    Bollig-Fischer, Aliccia
    Schwartz, Ann G.
    Gadgeel, Shirish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers
    Goeke, Friederike
    Franzen, Alina
    Hinz, Trista K.
    Marek, Lindsay A.
    Yoon, Petros
    Sharma, Rakesh
    Bode, Maike
    von Maessenhausen, Anne
    Lankat-Buttgereit, Brigitte
    Goeke, Antonia
    Golletz, Carsten
    Kirsten, Robert
    Boehm, Diana
    Vogel, Wenzel
    Kleczko, Emily K.
    Eagles, Justin R.
    Hirsch, Fred R.
    Van Bremen, Tobias
    Bootz, Friedrich
    Schroeck, Andreas
    Kim, Jihye
    Tan, Aik-Choon
    Jimeno, Antonio
    Heasley, Lynn E.
    Perner, Sven
    CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4356 - 4364
  • [6] Prognostic Significance of FGFR1 Amplification in Patients with Lung Squamous Cell Carcinoma
    Zhang, Qi
    Zhang, Xu-Chao
    Xie, Zhi
    Su, Jian
    Zhou, Qing
    Yang, Xue-Ning
    Zhong, Wen-Zhao
    Yang, Jin-Ji
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S291 - S292
  • [7] Fgfr1 Amplification In Squamous Cell Lung Cancer
    Gadgeel, S.
    Bepler, G.
    Schwartz, A.
    Land, S.
    Bollig-Fischer, A.
    Murphy, V.
    Cote, M.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S221 - S222
  • [8] FGFR1 Amplification in Squamous Cell Carcinoma of The Lung
    Heist, Rebecca S.
    Mino-Kenudson, Mari
    Sequist, Lecia V.
    Tammireddy, Swathi
    Morrissey, Laura
    Christiani, David C.
    Engelman, Jeffrey A.
    Iafrate, A. John
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (12) : 1775 - 1780
  • [9] PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
    Mueller, T.
    Braegelmann, J.
    Dietrich, D.
    Perner, S.
    Kristiansen, G.
    Bootz, F.
    Brossart, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 103 - 103
  • [10] PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
    Mueller, Tim
    Braun, Martin
    Dietrich, Dimo
    Aktekin, Seher
    Hoeft, Simon
    Kristiansen, Glen
    Goeke, Friederike
    Schroeck, Andreas
    Braegelmann, Johannes
    Held, Stefanie A. E.
    Bootz, Friedrich
    Brossart, Peter
    ONCOTARGET, 2017, 8 (32) : 52889 - 52900